NC
NASDAQ · NCNA
NuCana plc
Healthcare · Biotechnology
$1.06
Up+$0.03 (+2.83%)
Updated Oct 6, 2026, 10:37 PM
SID Score
2.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 24.41M
- P/E ratio
- -0.1
- Dividend yield
- 0.00%
- 52-week range
- $0.95 – $2.39
- Volume
- 71.75K
- Avg. volume
- 362.72K
Price performance · NCNA
NCNA price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
NCNA closed at $1.06 after 20 trading sessions, down 24.29% for the selected period.
- Last close
- $1.06
- Period change
- -24.29%
- Period low
- $1.06
- Period high
- $1.40
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $1.12 | $1.12 | $1.0301 | $1.06 | 71.75K |
| Oct 2, 2026 | $1.18 | $1.22 | $0.9484 | $1.09 | 326.01K |
| Oct 1, 2026 | $1.29 | $1.3131 | $1.01 | $1.17 | 804.73K |
| Sep 30, 2026 | $1.29 | $1.44 | $1.26 | $1.35 | 3.3M |
| Sep 29, 2026 | $1.29 | $1.29 | $1.21 | $1.21 | 24.81K |
| Sep 28, 2026 | $1.32 | $1.3695 | $1.26 | $1.29 | 23.67K |
| Sep 25, 2026 | $1.30 | $1.35 | $1.21 | $1.28 | 38.65K |
| Sep 24, 2026 | $1.31 | $1.34 | $1.2716 | $1.32 | 9.28K |
| Sep 23, 2026 | $1.33 | $1.35 | $1.30 | $1.31 | 27.84K |
| Sep 22, 2026 | $1.3477 | $1.38 | $1.30 | $1.33 | 20.55K |
| Sep 21, 2026 | $1.35 | $1.39 | $1.32 | $1.32 | 26.38K |
| Sep 18, 2026 | $1.33 | $1.385 | $1.32 | $1.34 | 10.97K |
| Sep 17, 2026 | $1.33 | $1.37 | $1.30 | $1.33 | 47.24K |
| Sep 16, 2026 | $1.31 | $1.3315 | $1.30 | $1.30 | 19.2K |
| Sep 15, 2026 | $1.32 | $1.35 | $1.30 | $1.30 | 65.81K |
| Sep 14, 2026 | $1.34 | $1.37 | $1.3105 | $1.32 | 13.69K |
| Sep 11, 2026 | $1.34 | $1.3624 | $1.32 | $1.32 | 25.12K |
| Sep 10, 2026 | $1.36 | $1.375 | $1.34 | $1.34 | 27.03K |
| Sep 9, 2026 | $1.40 | $1.44 | $1.37 | $1.37 | 17.2K |
| Sep 8, 2026 | $1.42 | $1.43 | $1.40 | $1.40 | 21.66K |
Latest NCNA news
The latest Smart Investors Daily articles mentioning NCNA.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…
